Back to results
US 8,557,779 B2Granted
Cancer vaccine composition
AssigneeInternational Institute of Cancer Immunology, Inc.
InventorHaruo Sugiyama
Life of this patent
Estimating the term…
Abstract
A cancer vaccine composition for human leukocyte antigen (HLA)-A*0206-positive persons, comprising a protein product of the tumor suppressor gene WT1 or a partial peptide thereof.
Claims4
A method of cancer treatment, comprising administering to an HLA-A*0206-positive person a composition containing a protein which is a gene product of the tumor suppressor gene WT1 or a partial peptide thereof.
Dependencies are inferred from the claim text.